SGTI — Shengtai Pharmaceutical Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Shengtai Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2012 June 30th | |
---|---|
Period Length: | 12 M |
Source: | 10-K |
Standards: | USG |
Status: | Final |
Net Income/Starting Line | 1.07 |
Depreciation | |
Amortisation | |
Non-Cash Items | -0.834 |
Other Non-Cash Items | |
Changes in Working Capital | -32 |
Change in Accounts Receivable | |
Change in Inventories | |
Change in Prepaid Expenses | |
Change in Accounts Payable | |
Change in Accrued Expenses | |
Change in Taxes Payable | |
Change in Other Liabilities | |
Cash from Operating Activities | -23.7 |
Capital Expenditures | -0.137 |
Purchase of Fixed Assets | |
Purchase / Acquisition of Intangibles | |
Other Investing Cash Flow Items | -1.52 |
Purchase of Investments | |
Other Investing Cash Flow | |
Cash from Investing Activities | -1.66 |
Financing Cash Flow Items | -4.11 |
Other Financing Cash Flow | |
Net Issuance / Retirement of Debt | |
Cash from Financing Activities | 26.1 |
Foreign Exchange Effects | |
Beginning Cash Balance | |
Ending Cash Balance | |
Net Change in Cash | 0.852 |